EUVIMEDEUVIMED entdecken
Crossref

Genome of a Carbapenem Resistant Acinetobacter baumannii Isolate of a new Sequence Type ST1724 from Saudi Arabia

Ahmed M Tolah, Muhammad Yasir, Asad Karim, Asad M Karim, Hani A Shukri, Esam I Azhar

Clinical Laboratory · 2025

DOI: 10.7754/clin.lab.2024.240926 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Laboratory, 2025. Verfasst von Ahmed M Tolah und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Carbapenems, Genome, Bacterial, Acinetobacter Infections.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The World Health Organization has classified carbapenem-resistant Acinetobacter baumannii as a pathogen of critical priority that poses a serious threat to human health. We report a draft genome sequence of colistin and carbapenem-resistant A. baumannii strain AB134 of a new sequence type ST1724. METHODS: A. baumannii strain AB34 was isolated from a tracheal aspirate specimen from a patient diagnosed with atherosclerotic disease and treated at a hospital in Saudi Arabia. Antimicrobial susceptibility was determined via microdilution using a VITEK 2 system. Genome sequencing was performed using a HiSeq 2500 platform (Illumina Inc., USA). RESULTS: A. baumannii strain AB134 was classified as a new sequence type (ST1724) comprised of 3,763 predicted genes and a guanine-cytosine content of 38.8%. The isolate was phenotypically resistant to 16 clinically important antibiotics, and 33 antimicrobial resistance genes were detected, including the beta-lactamase genes of blaOXA-23, blaOXA-66, blaADC-25, and blaTEM-1D. It carries the colistin resistance gene lpsB. In addition, 49 genes associated with virulence factors (biofilm formation, adherence, quorum sensing, iron uptake, and two-component system), and seven insertion sequences were detected in the AB134 genome. CONCLUSIONS: This report presents the first draft genome of ST1724 of carbapenem-resistant and extensively drug-resistant A. baumannii. The findings facilitate further understanding of the genomics of this pathogen, which is a leading cause of healthcare-associated infections worldwide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiCarbapenemsGenome, BacterialAcinetobacter InfectionsAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialHumansSaudi ArabiaMicrobial Sensitivity TestsWhole Genome Sequencing

Substanzen

CarbapenemsAnti-Bacterial Agents

Zitieren

APA

Tolah, A. M., Yasir, M., Karim, A., Karim, A. M., Shukri, H. A., & Azhar, E. I. (2025). Genome of a Carbapenem Resistant Acinetobacter baumannii Isolate of a new Sequence Type ST1724 from Saudi Arabia. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2024.240926

Vancouver

Tolah AM, Yasir M, Karim A, Karim AM, Shukri HA, Azhar EI. Genome of a Carbapenem Resistant Acinetobacter baumannii Isolate of a new Sequence Type ST1724 from Saudi Arabia. Clinical Laboratory. 2025. doi:10.7754/clin.lab.2024.240926

BibTeX
@article{Tolah2025,
  author = {Tolah, Ahmed M and Yasir, Muhammad and Karim, Asad and Karim, Asad M and Shukri, Hani A and Azhar, Esam I},
  title = {Genome of a Carbapenem Resistant Acinetobacter baumannii Isolate of a new Sequence Type ST1724 from Saudi Arabia},
  journal = {Clinical Laboratory},
  year = {2025},
  doi = {10.7754/clin.lab.2024.240926}
}
Kostenlos starten →